Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CYTR

CytRx

$1.06

0.03 (2.91%)

09:04
09/13/18
09/13
09:04
09/13/18
09:04
Hot Stocks
CytRx receives $250K milestone payment from Orphazyme A/S »

CytRx has received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTR

CytRx

$1.20

-0.04 (-3.23%)

08:37
07/25/18
07/25
08:37
07/25/18
08:37
Hot Stocks
CytRx subsidiary files provision patent application »

CytRx's private…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
CYTR

CytRx

$1.15

-0.05 (-4.17%)

09:08
06/28/18
06/28
09:08
06/28/18
09:08
Hot Stocks
CytRx's aldoxorubicin included in new NantCell breast cancer clinical trial »

CytRx highlighted that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTR

CytRx

$1.29

0.025 (1.98%)

09:15
06/21/18
06/21
09:15
06/21/18
09:15
Hot Stocks
CytRx highlights data on NantCell's aldoxorubicin »

CytRx highlighted data on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTR

CytRx

$1.33

0.01 (0.76%)

, NH

NantHealth

$3.50

0.02 (0.57%)

09:10
06/07/18
06/07
09:10
06/07/18
09:10
Hot Stocks
CytRx's aldoxorubicin shows lack of cardiac toxicity in clinical trials »

CytRx highlighted…

CYTR

CytRx

$1.33

0.01 (0.76%)

NH

NantHealth

$3.50

0.02 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTR

CytRx

$1.33

0.02 (1.53%)

09:09
06/04/18
06/04
09:09
06/04/18
09:09
Hot Stocks
CytRx announces formation, launch of Centurion BioPharma Corporation »

CytRx announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTR

CytRx

$1.33

0.01 (0.76%)

12:53
05/15/18
05/15
12:53
05/15/18
12:53
Hot Stocks
Breaking Hot Stocks news story on CytRx »

Sabby Management reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTR

CytRx

$1.88

-0.11 (-5.53%)

08:04
05/11/18
05/11
08:04
05/11/18
08:04
Syndicate
CytRx announces $7M registered direct offering »

CytRx announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVT

nVent Electric

$23.02

0.26 (1.14%)

, APY

Apergy

$0.00

(0.00%)

10:17
05/03/18
05/03
10:17
05/03/18
10:17
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

NVT

nVent Electric

$23.02

0.26 (1.14%)

APY

Apergy

$0.00

(0.00%)

BTAI

BioXcel Therapeutics

$7.50

(0.00%)

CYTR

CytRx

$1.83

0.06 (3.39%)

LAC

Lithium Americas

$5.16

0.05 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

CYTR

CytRx

$1.77

0.04 (2.31%)

08:35
05/03/18
05/03
08:35
05/03/18
08:35
Hot Stocks
CytRx names Eric Curtis as COO, effective May 3 »

CytRx announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.